Pharmacology of oxytocin and prostaglandins

Clinical Obstetrics and Gynecology

Volumn 43, Issue 3, 2000, Pages 455-468

  Arias, Fernando ^a  

^a TOLEDO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PROSTAGLANDIN;

BIOSYNTHESIS; DRUG EFFECT; FEMALE; HUMAN; LABOR INDUCTION; METABOLISM; PREGNANCY; REVIEW; UTERINE CERVIX RIPENING; UTERUS CONTRACTION;

CERVICAL RIPENING; FEMALE; HUMANS; LABOR, INDUCED; OXYTOCIN; PREGNANCY; PROSTAGLANDINS; UTERINE CONTRACTION;

EID: 0034266056     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200009000-00006     Document Type: Article

References (64)

1. Kamm KE, Stull JT. Myosin phosphorylation, force, and maximal shortening velocity in neurally stimulated tracheal smooth muscle. Am J Physiol. 1985;249:C238-C247.
2. Dokhac L, D'Albis A, Janmot C, et al. Myosin light chain phosphorylation in intact rat uterine smooth muscle. Role of calcium and cyclic AMP. Muscle Res. 1986; 7:259-268.
3. i, myosin light chain phosphorylation, and contraction in human myometrium. Am J Physiol. 1991;29: C861-C867.
4. Tansey MG, Word RA, Hidaka HA, et al. Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent protein kinase II in smooth muscle cells. J Biol Chem. 1992;267:12511-12516.
5. Higashi K, Fukunaga K, Matsui K, et al. Purification and characterization of myosin light-chain kinase from porcine myometrium and its phosphorylation and modulation by cyclic AMP-dependent protein kinase. Biochem Biophys Acta. 1983;747:232-240.
6. Adelstein RS, Conti MA, Hathaway DR, et al. Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine 3′.5′-monophosphate-dependent protein kinase. J Biol Chem. 1978; 253:8347-8350.
7. Sanborn BM. Ion channels and the control of myometrial electrical activity. Semin Perinatol. 1995;19:31-40.
8. Liggins GC. Cervical ripening as an inflammatory reaction. In: Ellwood DA and Anderson ABM, eds. The Cervix in Pregnancy and Labor: Clinical and Biochemical Investigations. Edinburgh, UK: Churchill Livingstone, 1981.
9. Chwalisz K. The use of progesterone antagonists for cervical ripening as an adjunct to labour and delivery. Hum Reprod. 1994; 9:131-161.
10. Rajabi MR, Dodge CR, Solomon S, Robin P. Immunochemical and immunohistochemical evidence of estrogen-mediated collagenolysis as a mechanism of cervical dilatation in the guinea pig at parturition. Endocrinology. 1991;128:371.
11. France JT, Seddon RJ, Liggins GC. A study of a pregnancy with low estrogen production due to placental sulfatase deficiency. J Clin Endocrinol Metab. 1973;36:1-9.
12. Shi SQ, Beier HM, Garfield RE, Chwalisz K. Local application of nitric oxide (NO) donor induces cervical ripening. J Soc Gynecol Invest. 1996;3:462.
13. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needelman P. Nitric oxide activates cyclooxygenases enzymes. Proc Nat Acad Sci USA. 1993;90:7240-7244.
14. Buhimschi L, Ali M, Jain V., et al. Differential regulation of nitric oxide in the uterus and cervix during pregnancy and labor. Hum Reprod. 1996;11:1755-1766.
15. Thomson AJ, Lunan CB, Cameron AD, et al. Nitric oxide donors induce ripening of the human uterine cervix: A randomized controlled trial. Br J Obstet Gynecol. 1997; 104:1054-1057.
16. Leake RD, Weitzman RE, Glatz TH, Fisher DA. Plasma oxytocin concentrations in men, nonpregnant women, and pregnant women before and during spontaneous labor. J C1 Endocrinol Metab 1981;53:730-733.
17. Cummiskey KC, Dawood MY. Induction of labor with pulsatile oxytocin. Am J Obstet Gynecol. 1990;163:1868-1874.
18. Dawood MY, Wang CF, Gupta R, Fuchs F. Fetal contribution to oxytocin in human labor. Obstet Gynecol. 1978;52:205.
19. Dawood MY, Ylikorkala O, Trivedi D, Fuchs F. Oxytocin in maternal circulation and amniotic fluid during pregnancy. J Clin Endocrinol Metab. 1979;49:429-434.
20. Cummiskey KC, Gall SA, Dawood MY. Pulsatile administration of oxytocin for induction of labor. Obstet Gynecol. 1989;74: 869-872.
21. Dawood MY, Ylikorkala O, Trivedi D, Gupta R. Oxytocin levels and disappearance rate and plasma follicle-stimulant hormone and luteinizing hormone after oxytocin infusion in man. J Clin Endocrinol Metab. 1980;50:397-400.
22. Seitchik J, Amico J, Robinson AG, Castillo M. Oxytocin augmentation of dysfunctional labor. IV. Oxytocin pharmacokinetics. Am J Obstet Gynecol. 1984;150:225-228.
23. Satin AJ, Leveno KJ, Sherman ML, McIntire D. High-dose oxytocin: 20-versus 40-minute dosage interval. Obstet Gynecol. 1994;83:234-238.
24. Orhue AAE. Incremental increases in oxytocin infusion regimens for induction of labor at term in primigravidas: A randomized controlled trial. Obstet Gynecol. 1994; 83:229-233.
25. Leake RD, Weitzman RE, Fisher DA. Pharmacokinetics of oxytocin in the human subject. Obstet Gynecol. 1980;56:701-704.
26. Lopez-Bernal A, Phipps SL, Rosevear SK, Turnbull AC. Mechanism of action of the oxytocin antagonist 1-deamino-2-D-Tyr-(OET)-4-Thr-8-Orn-oxytocin. Br J Obstet Gynecol. 1989;96:1108-1110.
27. Molnar M, Hertelendy F. Regulation of intracellular free calcium in human myometrial cells by prostaglandin F2 alpha: comparison with oxytocin. J Clin Endocrinol Metab. 1990;71:1243-1250.
28. Mironneau J. Ion channels and excitation -contraction coupling in myometrium. In: Garfield RE, ed. Uterine Contractility. Norwell MA: Serono Symposia USA, 1990.
29. Kim TT, Saunders T, Bieber E, Phillippe M. Tissue-specific protein kinase C isoform expression in rat uterine tissue. J Soc Gynecol Investig. 1999;6:293-300.
30. Husslein P, Fuchs AR, Fuchs F. Oxytocin and the initiation of human parturition. I. Prostaglandin release during induction of labor by oxytocin. Am J Obstet Gynecol. 1981;141:688-693.
31. Fusch AR, Fusch F, Husslein P, Soloff MS, Fernstrom MJ. Oxytocin receptors and human parturition: A dual role for oxytocin in the initiation of labor. Science. 1982;215: 1396-1398.
32. Jenkin G. Oxytocin and prostaglandin interactions in pregnancy and at parturition. J Reprod Fertil. 1992;45(suppl)97-111.
33. Molnar M, Rigo J, Romero R, Hertelendy F. Oxytocin activates mitogen-activated protein kinase and upregulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. Am J Obstet Gynecol. 1999;181:42-49.
34. Nohara A, Ohmichi M, Koike K, et al. The role of mitogen-activated protein kinase in oxytocin-induced contraction of uterine smooth muscle in pregnant rat. Biochem Biophys Res Commun. 1996;229:938-944.
35. Kimura T, Tanizawa O, Mori K, Browenstein MJ, Okayama H. Structure and expression of a human oxytocin receptor. Nature. 1992;356:526-529.
36. Bossmar T, Akerlund M, Fantoni G, Szamatowicks J, Melin P, Maggi M. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: Effect of the oxytocin antagonist atosiban. Am J Obstet Gynecol. 1994;171:1634-1642.
37. Lee CH, Park D, Wu D, Rhee SG, Simon MI. Member of the Gqa subunit gene family activate phospholipase Cβ isozymes. J Biol Chem. 1992;267:16044-16047.
38. Phaneuf S, Europe-Finner GN, Varney M, MacKenzie IZ, Watson SP, Lopez-Bernal A. Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: Involvement of pertussis toxin-sensitive and insensitive G-proteins. J Endocrinol. 1993; 136:497-509.
39. Hedin KE, Duerson K, Clapham DE. Specificity of receptor-G protein interactions: Searching for the structure behind the signal. Cellular Signaling. 1993;5:505-518.
40. Europe-Foinner GN, Phaneuf S, Watson SP, Lopez-Bernal A. Identification and expression of G proteins in human myometrium: Upregulation of Gas in pregnancy. Endocrinology. 1993;132:2484-2490.
41. Kniss DA. Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Invest. 1999;6:285-292.
42. 2α in corpus luteum regression. Adv Biosci. 1973;9:599-624.
43. 2 in guinea pig liver. Ann NY Acad Sci. 1971;180: 164-180.
44. 2α in female subjects. J Biol Chem. 1971;246:7470-7485.
45. Dubin NH, Johnson JW, Calhoun S, Ghodgaonkar RB, Beck JC. Plasma prostaglandin in pregnant women with term and preterm deliveries. Obstet Gynecol. 1981; 57:203-206.
46. Sanchez-Ramos L, Kaunitz AM, Wears RL, Delke I, Gaudier FL. Vaginal misoprostol for cervical ripening and labor induction: A meta-analysis. Obstet Gynecol. 1997;89:633-642.
47. Zieman M, Fong SK, Benowitz NL, Bankster D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:89-92.
48. Danielsson GK, Marions L, Rodriguez A, Spur BW, Wong PYK, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999;93:275-280.
49. Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1995;172:1804-1810.
50. Varaklis K, Gumina R, Stubblefield PG. Randomized controlled trial of vaginal misoprostol and intracervical prostaglandin E2 gel for induction of labor at term. Obstet Gynecol. 1995;86:541-544.
51. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoids receptors: structure, properties, and functions. Physiol Rev. 1999;79:1193-1226.
52. Molnar M, Hertelendy F. PGF2alpha and PGE2 binding to rat myometrium during gestation, parturition, and postpartum. Am J Physiol 1990;258:E740-E747.
53. Sakamoto K, Kamimura M, Kurozumi S, Ito S. Prostaglandin F2alpha receptor. J Lipid Mediators Cell Signaling. 1995;12: 405-411.
54. Boie Y, Stocco R, Sawyer N, et al. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor sub-types. Eur J Pharmacol. 1997;340:227-241.
55. Spaziani EP, O'Brien WF, Tsibris JCM, Benoit RR, Gould SS. Modulation of the prostaglandin E receptor: A possible mechanism for infection-induced preterm labor. Obstet Gynecol. 1999;93:84-88.
56. Breyer RM, Davis LS, Nian C, et al. Cloning and expression of the rabbit prostaglandin EP4 receptor. Am J Physiol. 1996;270: F485-F493.
57. Giannopoulos G, Jackson K, Kredenster J, Tulchinsky D. Prostaglandin E and F2alpha receptors in human myometrium during the menstrual cycle and in pregnancy and labor. Am J Obstet Gynecol. 1985;153:904-910.
58. Lee CH, Park D, Wu D, Rhee SG, Simon MI. Members of the Gqa subunit gene family activate Phospholipase Cβ isoenzymes. J Biol Chem. 1992;267:16044-16047.
59. Camps M, Carozzi A, Schnabel P, Parker PJ, Gierschink P. Isozime-selective stimulation of phospholipase C-β2 by G-protein βt subunits. Nature. 1992;360:684-686.
60. Ellwood DA, Mitchell MD, Anderson ABM, Turnbull AC. The in vitro production of prostanoids by the human cervix during pregnancy: Preliminary observations. Br J Obstet Gynaecol. 1980;87:210-214.
61. Uldbjerg N, Ekman G, Malmstrom A, et al. Biochemical and morphological changes of human cervix after local application of prostaglandins. Lancet. 1981;1:267-268.
62. Rath W, Adelman-Girill BC, Pieper U, et al. The role of collagenases and proteases in prostaglandin induced cervical ripening. Prostaglandins. 1987;34:119-127.
63. Norstrom A. Acute effects of prostaglandins on the biosynthesis of connective tissue constituents in the nonpregnant human cervix uteri. Acta Obstet Gynecol Scand. 1984;63:169-173.
64. Murota S, Abe M, Otsuka K. Stimulatory effect of prostaglandins on the production of hexosamine-containing substances by cultured fibroblasts. Prostaglandins. 1977; 14:983-991.